Cours Mabvax Therapeutics Holdings Inc Other OTC
Actions
US55414P7024
Recherche biotechnologique et médicale
CA 2016 | 148 k 134 k | CA 2017 | - | Capitalisation | 14,41 M 13,02 M |
---|---|---|---|---|---|
Résultat net 2016 | -17 M -15,36 M | Résultat net 2017 | -19 M -17,17 M | VE / CA 2016 | 147 x |
Dette nette 2016 | 470 k 425 k | Dette nette 2017 | 2,48 M 2,24 M | VE / CA 2017 | - |
PER 2016 |
-0,93
x | PER 2017 |
-0,25
x | Employés | - |
Rendement 2016 * |
-
| Rendement 2017 |
-
| Flottant | 92,02% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,44% | 122 Md | |
+18,94% | 114 Md | |
+19,62% | 25,71 Md | |
-25,37% | 19,02 Md | |
-20,21% | 15,83 Md | |
-20,20% | 15,32 Md | |
-47,37% | 14,88 Md | |
+59,91% | 14,82 Md | |
+4,35% | 14,1 Md |